NeuroOne Medical Technologies Corporation (NMTC) — Financial statements
Income statement, balance sheet, and cash flow for NeuroOne Medical Technologies Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 12↑250.4% | 3↑76.9% | 2↑1040.7% | 0.17↓3.9% | 0.18 | |
| Cost of Revenue | 4↑66.7% | 2↑58.7% | 1↑518.2% | 0.24↓12.3% | 0.28 | |
| Gross Profit | 8↑654.1% | 1↑136.5% | 0.46↑744.9% | -0.07↑27.6% | -0.10 | |
| Operating Expenses | ||||||
| R&D Expenses | 5↓1.6% | 5↓27.0% | 7↑40.8% | 5↑25.6% | 4 | |
| General & Administrative Expenses | 0.00↓100.0% | 8↑15.4% | 7↑0.7% | 7↑13.3% | 6 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 0.11↓37.2% | 0.17↓35.9% | 0.27↓20.1% | 0.34 | |
| SG&A Expenses | 7↓6.5% | 8↑14.1% | 7↓0.8% | 7↑11.5% | 6 | |
| Other Expenses | 0.00 | 0.00↑100.0% | -1↑25.3% | -2↓2907.0% | -0.06 | |
| Operating Expenses | 12↓4.6% | 13↑4.5% | 12↑24.6% | 10↓1.6% | 10 | |
| Total Costs & Expenses | 16↑6.4% | 15↑10.3% | 14↑36.3% | 10↓1.9% | 10 | |
| Operating Results | ||||||
| Operating Income | -4↑64.4% | -12↑0.6% | -12↓19.2% | -10↑1.8% | -10 | |
| Depreciation & Amortization | 0.26↑6.0% | 0.25↑23.9% | 0.20↑68.0% | 0.12↓19.4% | 0.15 | |
| EBITDA | -3↑74.6% | -12↓0.7% | -12↓18.6% | -10↓1.2% | -10 | |
| EBIT | -3↑72.9% | -12↓1.1% | -12↓19.2% | -10↓0.9% | -10 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.33↓45.9% | -0.23 | 0.00 | 0.00↑100.0% | -0.00 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.33↑45.9% | 0.23 | 0.00 | 0.00↓100.0% | 0.00 | |
| Non-Operating Income | -0.96↓573.1% | 0.20 | 0.00 | 0.00↑100.0% | -0.27 | |
| Other Income / Expenses | 0.62↑244.1% | -0.43↓550.0% | 0.10↑207.4% | 0.03↓88.5% | 0.27 | |
| Income Before Tax | -4↑70.7% | -12↓3.9% | -12↓18.6% | -10↓0.5% | -10 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -4↑70.7% | -12↓3.9% | -12↓18.6% | -10↓0.5% | -10 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -4↑70.7% | -12↓3.9% | -12↓18.6% | -10↓0.5% | -10 | |
| Bottom-Line Net Income | -4↑70.7% | -12↓3.9% | -12↓18.6% | -10↓0.5% | -10 | |
| EPS (Basic) | -0.54↑80.4% | -2.76↑29.2% | -3.90↓3.2% | -3.78↑32.3% | -5.58 | |
| EPS (Diluted) | -0.54↑80.4% | -2.76↑29.2% | -3.90↓3.2% | -3.78↑32.3% | -5.58 | |
| Weighted Average Shares | 7↑50.0% | 4↑47.7% | 3↑13.3% | 3↑49.6% | 2 | |
| Weighted Average Diluted Shares | 7↑50.0% | 4↑47.7% | 3↑13.3% | 3↑49.6% | 2 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.